Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and […]
Novartis unit Sandoz AG has lost its bid to revoke Bayerâs patents for its top-selling blood clot drug Xarelto and has been barred from selling […]
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns […]
CSIRO has won its bid to access samples of a wheat grain product with increased fibre, as it contemplates a possible patent infringement lawsuit against […]
German pharmaceutical giant Bayer has slammed generic drug make Sandozâs late bid for documents, which it called an attempt to âdivert and distractâ Bayer on […]
Global pharmaceutical giant Pfizer has successfully defended the patent for its sedative drug Precedex against a validity challenge, a big win for the drug maker […]